Evaluation of Hand Grip Strength in Pregnant COVID-19 Patients

August 6, 2023 updated by: Karaman Training and Research Hospital

Musculoskeletal Pain in Pregnant Infected With COVID-19, Evaluation of Fatigue and Muscle Grip Strength

It was presented as a cross-sectional, single-center, retrospective case series. Pregnant women with a positive Polymerase Chain Reaction (PCR) diagnosis of Covid 19 were included in the study. The relationship between patients' musculoskeletal symptoms and signs and hand grip strength was investigated.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Covid 19 is the disease defined for strains infected with severe acute respiratory syndrome coronavirus 2(Sars-CoV-2). Hand grip strength is a non-invasive, easily applicable, objective parameter. It was presented as a cross-sectional, single-center, retrospective case series. Pregnant women with a positive Polymerase Chain Reaction (PCR) diagnosis of Covid 19 were included in the study. The relationship between patients' musculoskeletal symptoms and signs and hand grip strength was investigated.

Study Type

Observational

Enrollment (Actual)

23

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Merkez
      • Karaman, Merkez, Turkey, 70200
        • Hatice Toprak

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

pregnant covid 19 patients

Description

Inclusion Criteria:

  • Pregnant women with a positive Polymerase Chain Reaction (PCR) diagnosis of Covid 19

Exclusion Criteria:

  • Those with orthopedic defects in the dominant hand and wrist and those with hand, wrist and shoulder involvement on the side of the measurement related to rheumatological diseases were excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
pregnant covid 19 patients
Device: Hand grip strength measureme
Hand grip strength (HSG) was measured in kg with the CAMRY Digital Hand Dynamometer (Model No. EH101, CAMRY).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hand grip strength assessment
Time Frame: The first 24 hours after admission to the service.
Hand grip strength assessment in pregnancy Covid 19.
The first 24 hours after admission to the service.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
symptoms
Time Frame: The first 24 hours after admission to the service.
Common symptoms of pregnant Covid 19 patients.
The first 24 hours after admission to the service.
laboratory findings
Time Frame: The first 24 hours after admission to the service.
Common laboratory findings of pregnant Covid 19 patients.
The first 24 hours after admission to the service.
Vaccine
Time Frame: pre-infection period was questioned
Vaccine rate of pregnant Covid 19 patients.
pre-infection period was questioned
Smoking
Time Frame: pre-infection period was questioned
Smoking rate of pregnant Covid 19 patients.
pre-infection period was questioned

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Karaman Training and Research Hospital

Investigators

  • Principal Investigator: Hatice Toprak, dr.tprk@hotmail.com

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2021

Primary Completion (Actual)

May 1, 2022

Study Completion (Actual)

May 30, 2022

Study Registration Dates

First Submitted

July 30, 2023

First Submitted That Met QC Criteria

July 30, 2023

First Posted (Actual)

August 1, 2023

Study Record Updates

Last Update Posted (Actual)

August 8, 2023

Last Update Submitted That Met QC Criteria

August 6, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 06-2022/10

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID-19

Clinical Trials on Hand grip strength measureme

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe